8:00 - 8:30 am
Registration Open & Continental Breakfast
8:30 - 8:40 am
Welcome
8:40 - 9:55 am
SESSION I: Advancing activity-based protein profiling Keriann Backus, PhD UCLA Ben Cravatt, PhD Scripps Research Institute Ekaterina Vinogradova, PhD Rockefeller University
9:55 - 10:15 am
Session 1 Panel Discussion
10:15 -10:25 am
Break
10:25 - 11:40 am
SESSION 2: Expanding covalency in drug design Paola Castaldi, PhD Matchpoint Therapeutics Kevan Shokat, PhD UCSF Jack Taunton, PhD UCSF
11:40 - 12:00 pm
Session 2 Panel Discussion
12:00 - 1:00 pm
Lunch
1:00 - 1:30 pm
Special MS Technology Lecture Brian Searle, PhD Ohio State University
1:30 - 2:00 pm
Lightning Trainee Talks Brendan Dwyer, PhD Stanford University Steven Shuken, PhD Harvard University Shizhong Dai, PhD Stanford University
2:00 - 2:10 pm
Break
2:10 - 3:25 pm
SESSION 3: Using mass spectrometry for target and ligand discovery Sherry Niessen, PhD Belharra Therapeutics Matt Patricelli, PhD Vividion Therapeutics Peter Jackson, PhD Stanford University
3:25 - 3:45 pm
Session 3 Panel Discussion
3:45 - 3:55 pm
Break
3:55 - 5:10 pm
SESSION 4: Developing proximity-based therapeutics Katelyn Cassidy, PhD C4 Therapeutics Katherine Donovan, PhD Dana Farber Cancer Institute Pete Wildes, PhD Revolution Medicines
5:10 - 5:30 PM
Session 4 Panel Discussion
5:30 - 5:35 PM
Closing remarks
5:35 - 6:15 PM
Reception